US20250102509A1
University of Texas System
Methods and systems that determine levels of leukemia or lymphoma are described. A model using biomarkers such as nuclear size, nuclear intensity, cellular density, and cell-to-nearest-neighbor distance may distinguish samples with chronic lymphocytic leukemia (CLL) progression, accelerated CLL ( …